Boston Scientific BSX Research and development expense
Research and development expense at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Boston Scientific's research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Boston Scientific's research and development expense?
- Boston Scientific (BSX) reported research and development expense of $516M in Q1 2026.
- How has Boston Scientific's research and development expense changed year-over-year?
- Boston Scientific's research and development expense increased by 16.5% year-over-year, from $443M to $516M.
- What is the long-term trend for Boston Scientific's research and development expense?
- Over 4 years (2021 to 2025), Boston Scientific's research and development expense has grown at a 14.3% compound annual growth rate (CAGR), from $1.2B to $2.05B.
- What does research and development expense mean?
- The money spent on researching and developing new products or improving existing ones.
- How do you interpret research and development expense?
- Higher spending indicates a commitment to innovation and future growth, while significantly lower spending may raise concerns about the long-term product pipeline.
- How does research and development expense compare across companies?
- Standard for technology and medical device firms; peers typically maintain high R&D spend to stay competitive.